» Articles » PMID: 21966627

Imaging-guided Parenchymal Liver Biopsy: How We Do It

Overview
Specialty Radiology
Date 2011 Oct 4
PMID 21966627
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Liver biopsies are performed for both focal and nonfocal lesions (parenchymal). In our center, majority of liver biopsies are performed for parenchymal liver disease. Parenchymal liver biopsy plays a key role in the diagnosis of various diffuse liver dysfunctions. Results of the biopsy help grade the disease, facilitating prognostication, which helps in planning specific treatment strategies. Imaging guidance is gaining wide acceptance as the standard procedure. Ultrasound (US) guidance is currently considered the most cost-effective and safe way to perform parenchymal liver biopsies. Radiologists worldwide and particularly in the United States are increasingly performing this procedure. Radiologists performing biopsies generally use the cutting needle. Different needle sizes, techniques and preference for biopsy of the right or left lobe have been described. We attribute these preferences to prior training and individual radiologist's comfort level. We describe the algorithm followed at our institution for performing percutaneous US-guided parenchymal liver biopsy. While clinical societies have recommended a minimum of 40 liver biopsies as a requirement for proficiency of clinicians, specific to radiology trainees/fellows interested in pursuing a career in intervention, we feel a total of 20 liver biopsies (includes assisted and independently performed biopsies under supervision) should be adequate training.

Citing Articles

Ultrasound-guided percutaneous liver biopsy: A review of what operators need to know.

Alturkistani H, Alsergani A, Alzeer M, Alturkistani A, Zaini R, Bauones S Medicine (Baltimore). 2024; 103(30):e38673.

PMID: 39058859 PMC: 11272270. DOI: 10.1097/MD.0000000000038673.


Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.

Shelley K, Articolo A, Luthra R, Charlton M BMC Gastroenterol. 2023; 23(1):160.

PMID: 37208593 PMC: 10197394. DOI: 10.1186/s12876-023-02794-4.


Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease.

Lupsor-Platon M, Serban T, Silion A, Tirpe G, Tirpe A, Florea M Cancers (Basel). 2021; 13(4).

PMID: 33672827 PMC: 7918928. DOI: 10.3390/cancers13040790.


Subcapsular local anesthesia approach in percutaneous liver biopsy: less pain, more comfort.

Cakir O, Aksu C Turk J Med Sci. 2020; 51(1):342-347.

PMID: 32967413 PMC: 7991882. DOI: 10.3906/sag-2006-346.


The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: a retrospective single-center study.

Ali A, Panchal S, Rao D, Gan Y, Al-Juboori A, Samiullah S J Ultrasound. 2020; 23(2):157-167.

PMID: 32141043 PMC: 7242589. DOI: 10.1007/s40477-020-00436-z.


References
1.
Bravo A, Sheth S, Chopra S . Liver biopsy. N Engl J Med. 2001; 344(7):495-500. DOI: 10.1056/NEJM200102153440706. View

2.
Karam A, Nugent W, Khan A, Desai D, Shankar S . Curved stylet core biopsy results in larger cores. AJR Am J Roentgenol. 2010; 195(1):242-4. DOI: 10.2214/AJR.09.3472. View

3.
Sporea I, Popescu A, Sirli R . Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol. 2008; 14(21):3396-402. PMC: 2716594. DOI: 10.3748/wjg.14.3396. View

4.
Tan K, Rajan D, Kachura J, Hayeems E, Simons M, Ho C . Pain after percutaneous liver biopsy for diffuse hepatic disease: a randomized trial comparing subcostal and intercostal approaches. J Vasc Interv Radiol. 2005; 16(9):1215-9. DOI: 10.1097/01.RVI.0000173282.14018.79. View

5.
Rockey D, Caldwell S, Goodman Z, Nelson R, Smith A . Liver biopsy. Hepatology. 2009; 49(3):1017-44. DOI: 10.1002/hep.22742. View